Details for New Drug Application (NDA): 219002
✉ Email this page to a colleague
NDA 219002 describes TRAMETINIB DIMETHYL SULFOXIDE, which is a drug marketed by Novugen and is included in one NDA. Additional details are available on the TRAMETINIB DIMETHYL SULFOXIDE profile page.
The generic ingredient in TRAMETINIB DIMETHYL SULFOXIDE is trametinib dimethyl sulfoxide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
The generic ingredient in TRAMETINIB DIMETHYL SULFOXIDE is trametinib dimethyl sulfoxide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
Summary for 219002
| Tradename: | TRAMETINIB DIMETHYL SULFOXIDE |
| Applicant: | Novugen |
| Ingredient: | trametinib dimethyl sulfoxide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG | ||||
| Approval Date: | Aug 6, 2024 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2MG | ||||
| Approval Date: | Aug 6, 2024 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
